Wells Fargo & Company Tela Bio, Inc. Transaction History

Wells Fargo & Company

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$5.3 - $7.61 $3,434 - $4,931	648 Added 15.47%	4,836 $27,000
Q4 2023 Feb 09, 2024	BUY	$4.5 - $7.51 $4,297 - $7,172	955 Added 29.54%	4,188 $27,000
Q3 2023 Nov 13, 2023	SELL	$7.85 - $10.68 $26,682 - $36,301	-3,399 Reduced 51.25%	3,233 $25,000
Q2 2023 Aug 15, 2023	BUY	$9.23 - $11.23 $60,484 - $73,590	6,553 Added 8294.94%	6,632 $67,000
Q1 2023 May 12, 2023	BUY	$9.41 - $12.03 $9 - $12	1 Added 1.28%	79 $0
Q4 2022 Feb 13, 2023	BUY	$6.5 - $11.5 $208 - $368	32 Added 69.57%	78 $0
Q3 2022 Nov 14, 2022	SELL	$7.36 - $9.15 $7 - $9	-1 Reduced 2.13%	46 $0
Q2 2022 Aug 12, 2022	BUY	$5.54 - $11.49 $22 - $45	4 Added 9.3%	47 $0
Q4 2021 Feb 14, 2022	BUY	$11.95 - $13.34 $11 - $13	1 Added 2.38%	43 $1,000
Q3 2021 Nov 15, 2021	SELL	$12.2 - $15.93 $97 - $127	-8 Reduced 16.0%	42 $1,000
Q2 2021 Aug 16, 2021	SELL	$11.7 - $16.11 $23,903 - $32,912	-2,043 Reduced 97.61%	50 $1,000
Q1 2021 May 13, 2021	SELL	$12.84 - $17.26 $85,707 - $115,210	-6,675 Reduced 76.13%	2,093 $31,000
Q4 2020 Feb 09, 2021	BUY	$14.61 - $17.59 $102,781 - $123,745	7,035 Added 405.94%	8,768 $132,000
Q3 2020 Nov 05, 2020	SELL	$11.64 - $16.86 $12,175 - $17,635	-1,046 Reduced 37.64%	1,733 $29,000
Q2 2020 Aug 13, 2020	BUY	$7.75 - $22.61 $21,335 - $62,245	2,753 Added 10588.46%	2,779 $36,000
Q1 2020 May 14, 2020	BUY	$5.39 - $18.33 $140 - $476	26 New	26 $0

20M

7.7K

1.1K

Ticker TELA
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 19,157,600
Market Cap $53.3M
Description
TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. It provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall recon...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.